R.O. Schlingemann

917 total citations
25 papers, 717 citations indexed

About

R.O. Schlingemann is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, R.O. Schlingemann has authored 25 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in R.O. Schlingemann's work include Retinal Diseases and Treatments (12 papers), Retinal Imaging and Analysis (8 papers) and Retinal and Optic Conditions (4 papers). R.O. Schlingemann is often cited by papers focused on Retinal Diseases and Treatments (12 papers), Retinal Imaging and Analysis (8 papers) and Retinal and Optic Conditions (4 papers). R.O. Schlingemann collaborates with scholars based in Netherlands, United States and Czechia. R.O. Schlingemann's co-authors include Henk M.W. Verheul, R. van Driel, Helma J.H. Kuijpers, F. C. S. Ramaekers, R. Verheijen, G. J. Brakenhoff, Annemie L. M. Boehmer, Frank D. Verbraak, Mirjam E. J. van Velthoven and H.G.T. Blaauwgeers and has published in prestigious journals such as Diabetes Care, Diabetes and Journal of Cell Science.

In The Last Decade

R.O. Schlingemann

25 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.O. Schlingemann Netherlands 10 275 251 191 112 77 25 717
Elisabeth Van Aken Belgium 18 514 1.9× 367 1.5× 318 1.7× 59 0.5× 177 2.3× 40 1.2k
G. Menicucci United States 5 207 0.8× 272 1.1× 112 0.6× 81 0.7× 27 0.4× 7 566
Sophie Valleix France 19 603 2.2× 160 0.6× 248 1.3× 9 0.1× 48 0.6× 50 1.0k
Bhavani S. Kowtharapu Germany 15 368 1.3× 63 0.3× 107 0.6× 18 0.2× 153 2.0× 27 684
Y Moromizato United States 7 371 1.3× 532 2.1× 380 2.0× 55 0.5× 38 0.5× 8 833
Esther Bandala‐Sanchez Australia 16 334 1.2× 32 0.1× 38 0.2× 22 0.2× 104 1.4× 27 762
Elissa A. Boguslawski United States 12 341 1.2× 64 0.3× 39 0.2× 13 0.1× 110 1.4× 20 575
P G McGuire United States 7 124 0.5× 88 0.4× 49 0.3× 11 0.1× 15 0.2× 10 467
Selina McHarg United Kingdom 12 223 0.8× 228 0.9× 108 0.6× 6 0.1× 27 0.4× 18 605
Jongkyu Choi United States 19 1.0k 3.7× 49 0.2× 42 0.2× 20 0.2× 164 2.1× 31 1.2k

Countries citing papers authored by R.O. Schlingemann

Since Specialization
Citations

This map shows the geographic impact of R.O. Schlingemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.O. Schlingemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.O. Schlingemann more than expected).

Fields of papers citing papers by R.O. Schlingemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.O. Schlingemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.O. Schlingemann. The network helps show where R.O. Schlingemann may publish in the future.

Co-authorship network of co-authors of R.O. Schlingemann

This figure shows the co-authorship network connecting the top 25 collaborators of R.O. Schlingemann. A scholar is included among the top collaborators of R.O. Schlingemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.O. Schlingemann. R.O. Schlingemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brink, Jacoline B. ten, R.O. Schlingemann, Theo G. M. F. Gorgels, et al.. (2017). Stem Cell Derived Retinal Pigment Epithelium: The Role of Pigmentation as Maturation Marker and Gene Expression Profile Comparison with Human Endogenous Retinal Pigment Epithelium.. Stem Cell Reviews and Reports. 13(5). 659–669. 22 indexed citations
2.
Schlingemann, R.O., et al.. (2012). A novel co‐culture model of the blood‐retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes. Acta Ophthalmologica. 90(s249). 0–0. 4 indexed citations
3.
Schlingemann, R.O., et al.. (2012). CD34 marks angiogenic tip cells in human vascular endothelial cell cultures: a new model to study mechanisms of ocular angiogenesis. Acta Ophthalmologica. 90(s249). 0–0. 15 indexed citations
4.
Verbraak, Frank D., Hille W. van Dijk, Pauline H. B. Kok, R.O. Schlingemann, & Michael D. Abràmoff. (2010). Reduced Retinal Thickness in Patients With Type 2 Diabetes Mellitus. 51(13). 4671–4671. 1 indexed citations
5.
Dijk, Hille W. van, et al.. (2008). White Spots in the Macula of Patients With Diabetes Mellitus Type 1, Without or With Minimal Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 49(13). 3215–3215. 1 indexed citations
6.
Dijk, Hille W. van, et al.. (2007). Preliminary OCT Findings: Macular Thickness in Patients With Diabetes Mellitus Type 2, With or Without Minimal Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 48(13). 1404–1404. 2 indexed citations
7.
Velthoven, Mirjam E. J. van, et al.. (2007). Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy. British Journal of Ophthalmology. 91(9). 1135–1138. 115 indexed citations
8.
Velthoven, Mirjam E. J. van, et al.. (2006). Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT. Graefe s Archive for Clinical and Experimental Ophthalmology. 244(9). 1119–1123. 29 indexed citations
9.
Hoyng, Carel B., Johannes R. Vingerling, J. M. M. Hooymans, et al.. (2005). AG–013958 (VEGFR Inhibitor) Achieves Effective Choroidal Concentrations With Minimal Systemic Effects in Cynomolgus Monkeys and Humans With Age–Related Macular Disease. 46(13). 2365–2365. 3 indexed citations
10.
Kuiper, Esther J., Marc D. de Smet, Jan C. van Meurs, et al.. (2004). Connective Tissue Growth Factor in vitreous correlates with fibrosis in vitreoretinal disorders in the human eye. 45(13). 4145–4145. 1 indexed citations
11.
Born, Bert‐Jan H. van den, R.O. Schlingemann, J. B. L. Hoekstra, & Gert A. van Montfrans. (2004). [Routine funduscopic examination in hypertensive patients not useful].. PubMed. 148(10). 464–8. 6 indexed citations
12.
Mathura, Keshen R., et al.. (2003). Orthogonal Polarization Spectral Imaging of the Conjunctival Microcirculation in Diabetes Mellitus. Investigative Ophthalmology & Visual Science. 44(13). 3601–3601. 1 indexed citations
13.
Verheul, Henk M.W., et al.. (2003). Are tumours angiogenesis‐dependent?. The Journal of Pathology. 202(1). 5–13. 91 indexed citations
14.
Alitalo, Kari, et al.. (2002). Expression Patterns of VEGF Receptors in Healthy Human and Monkey Retina: Involvement of VEGFs in Physiology?. Investigative Ophthalmology & Visual Science. 43(13). 2804–2804. 1 indexed citations
15.
Blaauwgeers, H.G.T., et al.. (2001). Role of VEGF-A in Endothelial Phenotypic Shift in Human Diabetic Retinopathy and VEGF-A-Induced Retinopathy in Monkeys. Ophthalmic Research. 33(3). 156–162. 34 indexed citations
16.
Witmer, Antonella N., J. van den Born, Gijs F.J.M. Vrensen, & R.O. Schlingemann. (2001). Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies. Current Eye Research. 22(3). 190–197. 17 indexed citations
17.
Schlingemann, R.O., Marcel Bruinenberg, P. Wertheim‐van Dillen, & Eric J. Feron. (1996). Twenty Years' Delay of Fellow Eye Involvement in Herpes Simplex Virus Type 2-Associated Bilateral Acute Retinal Necrosis Syndrome. American Journal of Ophthalmology. 122(6). 891–892. 42 indexed citations
18.
Holleman, F., et al.. (1995). Screening for Diabetic Retinopathy. Diabetes Care. 18(Supplement_1). 21–23. 3 indexed citations
19.
Schlingemann, R.O., Frank J.R. Rietveld, Robert M.W. de Waal, Soldano Ferrone, & D.J. Ruiter. (1989). Expression of the high molecular weight melanoma-associated antigen by percytes during antigionesis in tumors and in healing wounds. Ultramicroscopy. 31(4). 481–481. 3 indexed citations
20.
Verheijen, R., Helma J.H. Kuijpers, R.O. Schlingemann, et al.. (1989). Ki-67 detects a nuclear matrix-associated proliferation-related antigen : I. Intracellular localization during interphase. Journal of Cell Science. 92(1). 123–130. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026